Clinical Trial: 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 with Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865079) titled '53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 with Mild to Severe Tibio-Femoral Osteoarthritis of the Knee' on Feb. 25.

Brief Summary: 53-Week Study Evaluating the Safety and Efficacy of Intra-articular (IA) Injections of TPX-100 vs Placebo in Subjects with Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

Study Start Date: June 01, 2025

Study Type: INTERVENTIONAL

Condition: Osteoarthritis (OA) of the Knee

Intervention: DRUG: TPX-100 200 mg 4 times weekly for 4 weeks

TPX-100 (200 mg per dose) will be administered once-weekly (Week 1, 2, 3 & 4) to a single target knee of the su...